在脏疾病中的SUMOylation和NEDDylation
Zi-Han Chen1, Dan Li2, Jian-Yu Zhang1
1School of Life Science, Northwest University, Xi'an, Shaanxi, China.
Experimental and molecular pathology
|November 22, 2025
概括
翻译后的修改,SUMOylation和NEDDylation,显示出作为脏疾病的治疗点的希望. 调节这些过程可能为诸如脏缺血-再输损伤和糖尿病病等疾病提供新的治疗方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 由于治疗目标有限,病缺乏特定的治疗方法.
- 翻译后修饰 (PTMs),包括SUMOylation和NEDDylation,正在成为功能中的关键调节者.
- 这些类似于乌比奎丁的修饰影响了与脏健康相关的各种细胞过程.
研究的目的:
- 探索SUMOylation和NEDDylation作为脏疾病潜在治疗标的作用.
- 调查这些PTM如何影响不同的病,例如缺血-再输损伤和糖尿病病 (DKD).
- 评估针对SUMOylation和NEDDylation通路的激活剂和抑制剂的治疗潜力.
主要方法:
- 对病模型中的SUMOylation和NEDDylation现有研究的审查和分析.
- 检查调节特定的SUMOylation和NEDDylation目标 (例如,LKB1,HIF-1α,IKKγ,STAT1,RBMX,Notch1,Rhoa) 对病理的影响.
- 已知SUMOylation和NEDDylation调节剂 (例如,TAK-981,MLN4924) 的疗效评估.
主要成果:
- SUMOylation和NEDDylation调节缺血-再输液损伤和DKD中的关键通路.
- 特定的修饰,如LKB1 SUMOylation和HIF-1α deSUMOylation,影响纤维化,亡和氧化应激.
- 在DKD中,调节SUMOylation (IKKγ,STAT1,RBMX,Notch1) 和NEDDylation (RhoA) 可以减轻炎症,纤维化和细胞损伤.
- 这些PTM的激活剂和抑制剂在临床前研究中显示出治疗效果.
结论:
- 在病的发病和进展中,SUMOylation和NEDDylation是至关重要的.
- 针对这些PTM为各种脏疾病提供了一个有前途的治疗策略.
- SUMOylation和NEDDylation的激活剂和抑制剂代表了病治疗的新治疗候选者.
相关概念视频
Nephrons
6.3K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
6.3K
Nephrotic Syndrome I : Introduction
476
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
476
Nephrotic Syndrome II : Assessment and Medical Management
184
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
184
Covalently Linked Protein Regulators
8.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.6K
Phosphorylation
53.6K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
53.6K
Nephrotic Syndrome III : Nursing Management
271
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
271


